CCT3 and breast cancer: After 5 days, the MTT assay revealed that, compared with control cells (MDA-MB-231 OE-NC and T47D OE-NC), the proliferation rate was notably increased in CCT-3 overexpressed breast cancer cells (MDA-MB-231 OE and T47D OE).